Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-12-17 Purchase |
2020-12-17 5:47 pm |
Cyclo Therapeutics Inc. | CYTH | Ostronic Francis Patrick Director |
30,000 | $4.6583 | $139,748 | 58,559 (Direct) |
View |
2020-12-11 Purchase |
2020-12-14 4:03 pm |
Cyclo Therapeutics Inc. | CYTH | Sieger Markus Director |
15,000 | $0 | $0 | 87,729 (Direct) |
View |
2020-12-11 Purchase |
2020-12-14 4:03 pm |
Cyclo Therapeutics Inc. | CYTH | Toig Randall M. Director |
10,000 | $0 | $0 | 44,078 (Direct) |
View |
2020-12-11 Purchase |
2020-12-14 4:02 pm |
Cyclo Therapeutics Inc. | CYTH | SHANAHAN WILLIAM S Director |
20,000 | $0 | $0 | 83,677 (Direct) |
View |
2020-12-11 Purchase |
2020-12-14 4:02 pm |
Cyclo Therapeutics Inc. | CYTH | FINE N SCOTT Chief Executive Officer |
20,000 | $0 | $0 | 119,666 (Direct) |
View |
2020-11-23 Purchase |
2020-11-25 6:48 pm |
Cyclo Therapeutics Inc. | CTDH | Fine Joshua M Chief Financial Officer |
25,000 | $0.07696 | $1,924 | 685,000 (Direct) |
View |
2020-09-29 Sale |
2020-10-01 4:17 pm |
Cyclo Therapeutics Inc. | CTDH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
10,500 | $0.13476 | $1,415 | 31,591,538 (Indirect Direct) |
View |
2020-09-24 Sale |
2020-09-28 7:55 pm |
Cyclo Therapeutics Inc. | CTDH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
43,223 | $0.13 | $5,619 | 31,612,538 (Indirect Direct) |
View |
2020-09-21 Sale |
2020-09-23 7:01 pm |
Cyclo Therapeutics Inc. | CTDH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
167,000 | $0.14701 | $24,550 | 31,698,984 (Indirect Direct) |
View |
2020-09-14 Sale |
2020-09-16 8:12 pm |
Cyclo Therapeutics Inc. | CTDH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
337,084 | $0.16386 | $55,233 | 32,032,984 (Indirect Direct) |
View |
2020-09-09 Sale |
2020-09-11 5:59 pm |
Cyclo Therapeutics Inc. | CTDH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
1,003,070 | $0.17549 | $176,028 | 32,707,152 (Indirect Direct) |
View |
2020-09-03 Sale |
2020-09-08 7:13 pm |
Cyclo Therapeutics Inc. | CTDH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
1,504,961 | $0.16 | $240,794 | 34,713,652 (Indirect Direct) |
View |
2020-08-27 Purchase |
2020-09-02 4:03 pm |
Cyclo Therapeutics Inc. | CTDH | NOVIT L.P. Novit U.S. Inc. Kusmierz Katarzyna 10% Owner |
10,000,000 | $0 | $0 | 31,517,582 (Direct) |
View |
2020-08-27 Sale |
2020-08-31 7:33 pm |
Cyclo Therapeutics Inc. | CTDH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
165,263 | $0.11334 | $18,732 | 81,723,574 (Indirect Direct) |
View |
2020-08-27 Purchase |
2020-08-31 09:26 am |
Cyclo Therapeutics Inc. | CTDH | Sieger Markus Director |
750,000 | $0 | $0 | 6,522,857 (Direct) |
View |
2020-08-27 Purchase |
2020-08-31 07:49 am |
Cyclo Therapeutics Inc. | CTDH | SHANAHAN WILLIAM S Director |
700,000 | $0 | $0 | 5,067,660 (Direct) |
View |
2020-08-27 Purchase |
2020-08-28 4:06 pm |
Cyclo Therapeutics Inc. | CTDH | Ostronic Francis Patrick Director |
500,000 | $0 | $0 | 3,355,890 (Direct) |
View |
2020-08-27 Purchase |
2020-08-28 4:06 pm |
Cyclo Therapeutics Inc. | CTDH | FINE N SCOTT Chief Executive Officer |
500,000 | $0 | $0 | 8,466,513 (Direct) |
View |
2020-04-24 Purchase |
2020-04-27 4:07 pm |
Cyclo Therapeutics Inc. | CTDH | FINE N SCOTT Chief Executive Officer |
730,030 | $0.1 | $73,003 | 7,466,513 (Direct) |
View |
2020-04-24 Purchase |
2020-04-27 4:06 pm |
Cyclo Therapeutics Inc. | CTDH | Toig Randall M. Director |
1,000,000 | $0.1 | $100,000 | 2,407,770 (Direct) |
View |
2020-04-24 Purchase |
2020-04-27 4:05 pm |
Cyclo Therapeutics Inc. | CTDH | Sieger Markus Director |
500,000 | $0.1 | $50,000 | 5,022,857 (Direct) |
View |
2020-04-24 Purchase |
2020-04-27 4:05 pm |
Cyclo Therapeutics Inc. | CTDH | NOVIT L.P. Novit U.S. Inc. Kusmierz Katarzyna 10% Owner |
2,000,000 | $0.1 | $200,000 | 11,517,582 (Direct) |
View |
2020-04-24 Purchase |
2020-04-27 4:04 pm |
Cyclo Therapeutics Inc. | CTDH | Ostronic Francis Patrick Director |
1,000,000 | $0.1 | $100,000 | 2,355,890 (Direct) |
View |
2020-04-24 Purchase |
2020-04-27 4:04 pm |
Cyclo Therapeutics Inc. | CTDH | SHANAHAN WILLIAM S Director |
1,000,000 | $0.1 | $100,000 | 3,667,660 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2021-01-13 Option Award |
2021-01-25 8:01 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Fine Joshua M Chief Financial Officer |
10,000 | $0 | 16,850 (Direct) |
View |
2020-12-11 Option Award |
2020-12-14 4:04 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | TATE JEFFREY Chief Operating Officer |
5,000 | $0 | 20,160 (Direct) |
View |
2020-12-11 Option Award |
2020-12-14 4:04 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CYTH | Hrynkow Sharon Hemond Chief Scientific Officer |
1,000 | $0 | 8,350 (Direct) |
View |
Ownership |
2020-09-24 09:40 am |
N/A N/A |
Cyclo Therapeutics Inc. | CTDH | Lisjak Michael Eric Chief Regulatory Officer |
0 | $0 | 240,000 (Direct) |
View |
Ownership |
2020-08-31 7:13 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CTDH | ARMISTICE CAPITAL LLC Armistice Capital Master Fund Ltd. Boyd Steven 10% Owner |
0 | $0 | 82,054,100 (Direct) |
View |
2020-04-24 Option Award |
2020-04-27 4:06 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CTDH | TATE JEFFREY Chief Operating Officer |
50,000 | $0.1 | 1,015,972 (Direct) |
View |
2020-04-24 Option Award |
2020-04-27 4:06 pm |
N/A N/A |
Cyclo Therapeutics Inc. | CTDH | Hrynkow Sharon Hemond Chief Scientific Officer |
200,000 | $0.1 | 635,000 (Direct) |
View |